Takeda Calls $2.2B Actos Settlement Report 'Rumor'

Law360, New York (April 2, 2015, 6:30 PM EDT) -- Takeda Pharmaceutical Co. on Thursday appeared to dismiss as "marketplace rumors" news reports claiming the drugmaker plans to pay $2.2 billion to settle thousands of federal and state suits over the alleged cancer risks of its diabetes drug Actos.

Takeda spokeswoman Sandy Rodriguez told Law360 in a statement Thursday that the drugmaker would not comment on "marketplace rumors," declining to confirm a Bloomberg report that cited confidential sources claiming the drugmaker plans to pay $2.2 billion to settle some 8,000 suits in the litigation. 

"Takeda has confidence...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.